Jeremy Han
Garvan Institute of Medical Research, NSW, Australia
Presentations this author is a contributor to:
Rationalising the inclusion of HDAC inhibitors with standard-of-care chemotherapy for high-risk neuroblastoma (#238)
5:35 PM
Monica Phimmachanh
Poster Session 2
CANCER 2026